Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann Nadjar

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|October 22, 2020
Late-onset riboflavin transporter deficiency: a treatable mimic of various motor neuropathy aetiologiesChristophe Carreau, Charline Benoit, Guido Ahle, et al.
Journal of the Neurological Sciences|February 1, 2011
Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosisHélène Blasco, Patrick Vourc'h, Yann Nadjar, et al.
Annals of Neurology|January 30, 2020
Natural History of Adult Patients with GM2 GangliosidosisMarion Masingue, Louis Dufour, Timothée Lenglet, et al.
Orphanet Journal of Rare Diseases|December 13, 2022
Prospective cholestanol screening of cerebrotendinous xanthomatosis among patients with juvenile-onset unexplained bilateral cataractsGorka Fernández-Eulate, Gilles C Martin, Pascal Dureau, et al.
Journal of Neurology|May 23, 2019
Cholic acid as a treatment for cerebrotendinous xanthomatosis in adultsDaniele Mandia, Annabelle Chaussenot, Gérard Besson, et al.
Molecular Genetics and Metabolism|January 29, 2023
Plasma G<sub>M2</sub> ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-GangliosidosisAmélie Blondel, Ichraf Kraoua, Chloé Marcelino, et al.
Journal of Clinical Medicine|May 7, 2020
A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry DiseaseAbdellah Tebani, Wladimir Mauhin, Lenaig Abily-Donval, et al.
Journal of Inherited Metabolic Disease|April 24, 2020
Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: A large retrospective observational studyMarc C Patterson, William S Garver, Robert Giugliani, et al.
Human Molecular Genetics|February 4, 2020
Mutation m.3395A > G in MT-ND1 leads to variable pathologic manifestationsNicolás Gutiérrez Cortés, Claire Pertuiset, Elodie Dumon, et al.
Frontiers in Neurology|November 17, 2025
Expanding the spectrum of white matter abnormalities in Wolfram syndrome: a retrospective reviewJustin Simo, Heather M Lugar, Elka Miller, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Neurology, Neurosurgery, and Psychiatry|October 22, 2020
Late-onset riboflavin transporter deficiency: a treatable mimic of various motor neuropathy aetiologiesChristophe Carreau, Charline Benoit, Guido Ahle, et al.
Journal of the Neurological Sciences|February 1, 2011
Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosisHélène Blasco, Patrick Vourc'h, Yann Nadjar, et al.
Annals of Neurology|January 30, 2020
Natural History of Adult Patients with GM2 GangliosidosisMarion Masingue, Louis Dufour, Timothée Lenglet, et al.
Orphanet Journal of Rare Diseases|December 13, 2022
Prospective cholestanol screening of cerebrotendinous xanthomatosis among patients with juvenile-onset unexplained bilateral cataractsGorka Fernández-Eulate, Gilles C Martin, Pascal Dureau, et al.
Journal of Neurology|May 23, 2019
Cholic acid as a treatment for cerebrotendinous xanthomatosis in adultsDaniele Mandia, Annabelle Chaussenot, Gérard Besson, et al.
Molecular Genetics and Metabolism|January 29, 2023
Plasma G<sub>M2</sub> ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-GangliosidosisAmélie Blondel, Ichraf Kraoua, Chloé Marcelino, et al.
Journal of Clinical Medicine|May 7, 2020
A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry DiseaseAbdellah Tebani, Wladimir Mauhin, Lenaig Abily-Donval, et al.
Journal of Inherited Metabolic Disease|April 24, 2020
Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: A large retrospective observational studyMarc C Patterson, William S Garver, Robert Giugliani, et al.
Human Molecular Genetics|February 4, 2020
Mutation m.3395A > G in MT-ND1 leads to variable pathologic manifestationsNicolás Gutiérrez Cortés, Claire Pertuiset, Elodie Dumon, et al.
Frontiers in Neurology|November 17, 2025
Expanding the spectrum of white matter abnormalities in Wolfram syndrome: a retrospective reviewJustin Simo, Heather M Lugar, Elka Miller, et al.
Pageof 6